+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Esperion Therapeutics Inc - logo
Hyperlipidemia Drugs - Global Strategic Business Report - Product Thumbnail Image

Hyperlipidemia Drugs - Global Strategic Business Report

  • Report
  • December 2023
  • 94 Pages
  • Global
From
Hyperlipidemia Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 - Product Thumbnail Image

Hyperlipidemia Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • Report
  • November 2023
  • 142 Pages
  • Global
From
Cardiovascular Collaboration and Licensing Deals 2016-2023 - Product Thumbnail Image

Cardiovascular Collaboration and Licensing Deals 2016-2023

  • Report
  • October 2023
  • 300 Pages
  • Global
From
Hyperlipidemia Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Hyperlipidemia Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • January 2022
  • 117 Pages
  • Global
From
Novel Drug Reconstitution Systems Market by Type of Container, Fabrication Material, Physical State of Drug in Syringe and Cartridge, Physical State of Drug in Infusion Bag, Volume of Container, Key Geographical Regions: Industry Trends and Global Forecasts, 2021-2030 - Product Thumbnail Image

Novel Drug Reconstitution Systems Market by Type of Container, Fabrication Material, Physical State of Drug in Syringe and Cartridge, Physical State of Drug in Infusion Bag, Volume of Container, Key Geographical Regions: Industry Trends and Global Forecasts, 2021-2030

  • Report
  • September 2021
  • 325 Pages
  • Global
From
Heterozygous familial hypercholesterolemia (heFH) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Heterozygous familial hypercholesterolemia (heFH) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 63 Pages
  • Global
From
Hypercholesterolemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hypercholesterolemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 210 Pages
  • Global
From
Dyslipidemia by Major Markets - Size, Trends and Drug Forecast including Epidemiology, Disease Management, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Pipeline Analysis to 2032 - Product Thumbnail Image

Dyslipidemia by Major Markets - Size, Trends and Drug Forecast including Epidemiology, Disease Management, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Pipeline Analysis to 2032

  • Drug Pipelines
  • July 2023
  • 144 Pages
  • Global
From
Niemann Pick C1 Like Protein 1 Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Niemann Pick C1 Like Protein 1 Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • August 2023
  • 81 Pages
  • Global
From
Dyslipidemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Dyslipidemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 330 Pages
  • Global
From
Global Hypercholesterolemia Drug Market by Mechanism of Action (Bile Acid Sequestrants, Fibric Acid Derivatives, HMG-CoA Reductase Inhibitors), Type of Disease (Familial hypercholesterolemia (FH), Non-Familial hypercholesterolemia (FH)), Drug Class - Forecast 2023-2030 - Product Thumbnail Image

Global Hypercholesterolemia Drug Market by Mechanism of Action (Bile Acid Sequestrants, Fibric Acid Derivatives, HMG-CoA Reductase Inhibitors), Type of Disease (Familial hypercholesterolemia (FH), Non-Familial hypercholesterolemia (FH)), Drug Class - Forecast 2023-2030

  • Report
  • October 2023
  • 188 Pages
  • Global
From
Non-Alcoholic Steatohepatitis (NASH) (Gastrointestinal) - Drugs in Development, 2021 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) (Gastrointestinal) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
Global Atherosclerosis Drugs Market Report 2023 - Product Thumbnail Image

Global Atherosclerosis Drugs Market Report 2023

  • Report
  • October 2023
  • 175 Pages
  • Global
From
Atherosclerotic Cardiovascular Disease (ASCVD) - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Atherosclerotic Cardiovascular Disease (ASCVD) - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • November 2023
  • 255 Pages
  • Global
From
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Global Hypercholesterolemia Drug Market (2022-2027) by Drug Class, Mechanism of Action, Type of Disease, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis - Product Thumbnail Image

Global Hypercholesterolemia Drug Market (2022-2027) by Drug Class, Mechanism of Action, Type of Disease, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis

  • Report
  • May 2022
  • 190 Pages
  • Global
From
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor - Pipeline Insight, 2022 - Product Thumbnail Image

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor - Pipeline Insight, 2022

  • Clinical Trials
  • January 2022
  • 60 Pages
  • Global
From
Heterozygous Familial Hypercholesterolemia Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

Heterozygous Familial Hypercholesterolemia Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • July 2023
  • 73 Pages
  • Global
From
Acute Coronary Syndrome Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Acute Coronary Syndrome Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • April 2023
  • 94 Pages
  • Global
From
Cholesterol Absorption Inhibitor - Pipeline Insight, 2022 - Product Thumbnail Image

Cholesterol Absorption Inhibitor - Pipeline Insight, 2022

  • Clinical Trials
  • January 2022
  • 60 Pages
  • Global
From
Loading Indicator